1450 Research Boulevard to Bring 45,000 Square Feet of Amenity-Rich Lab Space to Rockville

Collage depicting 1450 Research Blvd building, an image of the exterior, and the South Duvall logo
Published on :

South Duvall, the Rockville-based life science real estate investor, is set to convert an office building at 1450 Research Boulevard to 45,000 square feet of lab space. The Rockville building, which South Duvall submitted plans for earlier in January, will be flush with amenities and suitable for one or multiple tenants.

Horizon Therapeutics plc Announces Significant Expansion of East Coast Research and Development and Technical Operations Capability

Horizon Therapeutics logo
Published on :

Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has signed a long-term, full-building lease with Alexandria Real Estate Equities, Inc. to be the first tenant at the Alexandria Center® at Traville Gateway campus in Rockville, Maryland. When completed, the state-of-the-art facility will serve as the company’s primary East Coast research and development and technical operations hub. Construction at the 192,000-square-foot site is underway and Horizon expects to start work on interior improvements in 2023. Additional terms of the agreement were not disclosed.

Texcell North America Marks Expansion by Breaking Ground for New Facility

Photo of Texcell's ground breaking ceremony in Frederick, MD
Published on :

Texcell – North America, Inc., part of the Texcell Group of global biosafety contract research organizations, held a breaking ground ceremony for a new facility on December 6, 2021, in Frederick, MD. The expansion is a next step in Texcell’s growth trajectory as they increase capabilities for all their service lines, including customized R&D cell culture, GLP viral clearance studies, and select GMP assay capabilities for viral safety testing. The multimillion-dollar facility will add 27,000 square feet of laboratory and office space, more than doubling Texcell’s current capacity for biosafety testing and viral clearance studies. The completion date is projected for the first quarter of 2023.

Maryland Real Estate Roundup 2021

Collage with photos of Baltimore, Frederick, the Maryland flag, blue crabs, and text saying "Maryland Real Estate Roundup 2021"
Published on :

This year, Maryland continued to prove why it’s becoming one of the strongest biohealth clusters in the country. The state’s commitment to businesses in the life science, pharmaceutical, and biotech industries has continued as both the private and public sectors work to meet the demand for more space. Here are a few of the biggest real estate projects in Maryland in 2021. Some of these projects are still under construction, while others were unveiled this year. 

Federal Realty Plans to Offer Employers Amenity-rich Space at 935 Prose

Photo of the planned 935 Prose Street building
Published on :

Federal Realty, the developers of Pike & Rose, recently announced the development of 935 Prose Street, a 10-story building right near the intersection of Montrose Parkway and Rockville Pike. The building adds to the company’s recent foray into the biotech space, with another project at Assembly Row in Somerville, Massachussetts. Ignoring the market demand for real estate in this sector the last few years was near impossible, said Federal Realty’s VP of Development, Jay Brinson. 

Early Charm Announces Doubling of Production and Development Space at Baltimore’s 1100 Wicomico

Published on :

November 2, 2021, Baltimore, MD – In a move to accommodate its continued fast growth, Early Charm – a company that creates, owns and operates ventures that convert science to revenue – announced today it is more than doubling its production and lab space at Baltimore’s 1100 Wicomico building.
This significant expansion will occur adjacent to Early Charm’s 2,150 square feet of current production and development space, bringing total production and development space to just under 5,000 square feet.
“Demand for our custom manufactured products is strong across the board with nanofibers, 3D printing, DNA libraries and custom inks experiencing the most rapid growth,” said Ken Malone, Executive Officer with Early Charm. “We’ve already removed the wall separating the spaces and will be able to use a large portion of the space immediately. The full build-out will only take a few months.”

Catalent Invests Additional $230 Million to Expand its State-of-the-Art Gene Therapy Commercial Manufacturing Campus in Harmans, Maryland

Published on :

Catalent Invests Additional $230 Million to Expand its State-of-the-Art Gene Therapy Commercial Manufacturing Campus in Harmans, Maryland

Tonix Pharmaceuticals Announces Ribbon-Cutting Ceremony for its Infectious Disease R&D Center in Maryland

Published on :

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced it will hold a ribbon-cutting ceremony at the Company’s approximately 48,000 square foot research and development center (RDC) in Frederick, Md. on October 18, 2021 at 12:00 p.m. ET. The RDC is expected to support the Company’s expanding infectious disease pipeline. This includes providing internal capacity to discover and develop vaccines and antivirals intended to support U.S. pandemic preparedness.

NOVA BioScience Center Addresses Critical Wet Lab Space Needs for Region

Published on :

Prince William County and VirginiaBio recently welcomed visitors to the new 33,000 square feet of wet lab space at the Northern Virginia BioScience Center, showcasing the county’s work toward becoming a life sciences hotspot. 

VaLogic acquires vacant Frederick building to create tech hub

Published on :

Biotech company VaLogic has acquired a 75,400-square-foot building in Frederick to create a suburban tech center near Interstate 270.
The company bought a vacant commercial building at 7495 New Horizon Way for $7.7 million and soon will begin to gut and redo the interior to create the new office and lab space to lease to several smaller companies.
VaLogic for years has consulted on engineering and compliance issues for life science and bioscience companies. It is one of dozens of existing bioscience companies in the county, which is considered a suburb of both Baltimore and Washington, D.C. because of its location off Interstates 70 and 270.